Advisory
Board
Ferid Murad, MD,
PhD
1998 Nobel Laureate, Member National
Academy of Sciences, Professor, University of Texas Medical School and Director
of the Institute of Molecular Medicine. Former VP Research and Development
at Abbott and former CEO of Molecular Geriatrics (a VC funded start-up). Currently
serves as Scientific Advisor for other life science companies.
Barry
J. Marshall, MD
Professor
Barry J. Marshall is co-recipient of the 2005 Nobel Prize in Physiology and
Medicine for the elucidation of the role of Helicobacter pylori in gastric
ulcerogenesis. He is Clinical Professor of Microbiology and Medicine at the
University of Western Australia and has been involved with a successfully
commercialized drug and multiple diagnostic tests.
Joe
Wernicke, MD, PhD
Sr. Research Physician, Eli Lilly
and Company. Lead the regulatory development of Lilly’s blockbuster
drug Prozac® as well as Strattera®. Former VP of Clinical and
Regulatory Affairs for Cyberonics, Inc.
Haile
T. Debas, MD
Executive
Director of Global Health Sciences, University of California, San Francisco
(UCSF), the Maurice Galante Distinguished Professor of Surgery, dean emeritus
of the School of Medicine, vice chancellor emeritus for medical affairs and
chancellor emeritus.
Kim
D. Rainsford, PhD, FRCP Edin, FRCPath, FRSC, FIBiol, FIBMS, Dr(hc)
An internationally
recognized NSAID expert, Professor Rainsford has been involved with various
academic institutions, consulted with Pharmaceutical companies, edited well
known journals and authored many publications and books related to NSAIDs.
Brendan
J.R. Whittle B.Pharm., Ph.D., D.Sc.
Dr. Whittle is an internationally recognized expert
in gastrointestinal pharmaceutical research and development, with industry
and academic experience. He is one of the 100 most cited scientists and well
known for his efforts in understanding the mechanisms of NSAID damage.
Gilbert Castro, PhD
Dr. Castro is an internationally recognized expert on gastrointestinal
mucosal inflammation. He is now retired, having served many years in senior
leadership positions within the University of Texas System institutions.
Sandor
Szabo, MD, PhD
Chief of Staff and Chairman of
Pathology and Laboratory Medicine, VA Medical Center - Long Beach. Associate
Dean and Professor, UC-Irvine. Former FDA Gastrointestinal Advisory Panel
Member. Holder of multiple patents for the treatment of GI ulcers.
Don
Friedkin
Retired pharmaceutical executive
who brings significant manufacturing and OTC experience. Mr. Friedkin’s
career includes executive positions with Biovail and Nysco Laboratories until
it’s sale to Revlon.
Robert
Strozier, JD, PhD
A patent attorney with experience
in domestic and international law specializing in biopharmaceutical intellectual
property. He has represented major universities and life science startup companies.
Previously he worked in industry as a chemist (Ph.D.) for Goodyear.